Yaling Zheng
600 Yishan Road
Shanghai, 200233, China
Shanghai, 200233, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Association of uric acid levels with the risk of severe CED in LVO-AIS patients after mechanical thrombectomy.
Journal: Frontiers in neurology
Published: December 22, 2025
PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB/CD44 pathway.
Journal: International immunopharmacology
Published: August 21, 2023
Network pharmacology-based strategy to investigate pharmacological mechanisms of Andrographolide for treatment of vascular cognitive impairment.
Journal: International immunopharmacology
Published: December 20, 2021
NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway.
Journal: Journal of neuroinflammation
Published: June 14, 2021
Andrographolide ameliorates neuroinflammation in APP/PS1 transgenic mice.
Journal: International immunopharmacology
Published: March 20, 2021
Curcumin protects against cognitive impairments in a rat model of chronic cerebral hypoperfusion combined with diabetes mellitus by suppressing neuroinflammation, apoptosis, and pyroptosis.
Journal: International immunopharmacology
Published: December 16, 2020
TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus.
Journal: Journal of neuroinflammation
Published: October 31, 2019
Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells.
Journal: Molecular immunology
Published: May 22, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026